Literature DB >> 3139012

The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.

L H Gold1, N R Swerdlow, G F Koob.   

Abstract

Daily administration of psychomotor stimulants in a distinctive environment can impart on the environment stimulantlike properties. Rats injected with amphetamine (0.75 mg/kg, sc) daily for 5 days exhibited a robust unconditioned locomotor response, measured in photocell cages, and showed a conditioned locomotor response when treated with saline on the 6th day. This conditioned locomotor response was found to be significantly attenuated by 6-hydroxydopamine (6-OHDA) lesions of the nucleus accumbens when the lesion was made either pre- or postconditioning. Similarly, although rats with 6-OHDA lesions of the nucleus accumbens exhibited a robust supersensitive unconditioned locomotor hyperactivity in response to apomorphine (0.1 mg/kg, sc), they did not show a conditioned response on the test day. These results suggest that the mesolimbic dopamine system may be responsible for both the unconditioned and conditioned locomotor responses to psychomotor stimulant drugs. Further, conditioned locomotion depends on a critical interaction between the physiological release of presynaptic dopamine and occupation of postsynaptic receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3139012     DOI: 10.1037//0735-7044.102.4.544

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  29 in total

1.  Dopamine and conditioned reinforcement. I. Differential effects of amphetamine microinjections into striatal subregions.

Authors:  A E Kelley; J M Delfs
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine.

Authors:  B A Mattingly; J K Rowlett; J T Graff; B J Hatton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine.

Authors:  S E Hemby; G H Jones; J B Justice; D B Neill
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Traumatic brain injuries during development disrupt dopaminergic signaling.

Authors:  Kate Karelina; Kristopher R Gaier; Zachary M Weil
Journal:  Exp Neurol       Date:  2017-08-09       Impact factor: 5.330

5.  MDMA produces stimulant-like conditioned locomotor activity.

Authors:  L H Gold; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Pharmacological manipulation of the dopaminergic system affects wheel-running activity in differentially active mice.

Authors:  A M Knab; R S Bowen; A T Hamilton; J T Lightfoot
Journal:  J Biol Regul Homeost Agents       Date:  2012 Jan-Mar       Impact factor: 1.711

7.  Development and persistence of methamphetamine-conditioned hyperactivity in Swiss-Webster mice.

Authors:  Anthony Sean Rauhut; Victoria Bialecki
Journal:  Behav Pharmacol       Date:  2011-06       Impact factor: 2.293

8.  PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.

Authors:  Karen K Szumlinski; Alexis W Ary; Christina B Shin; Melissa G Wroten; Justin Courson; Bailey W Miller; Micaela Ruppert-Majer; John W Hiller; John R Shahin; Osnat Ben-Shahar; Tod E Kippin
Journal:  Addict Biol       Date:  2018-11-18       Impact factor: 4.280

9.  The contribution of the central nucleus of the amygdala to individual differences in amphetamine-induced hyperactivity.

Authors:  Mary E Cain; Rosemary A Coolon; Margaret J Gill
Journal:  Behav Brain Res       Date:  2009-03-19       Impact factor: 3.332

10.  Retarded acquisition and reduced expression of conditioned locomotor activity in adult rats following repeated early maternal separation: effects of prefeeding, d-amphetamine, dopamine antagonists and clonidine.

Authors:  K Matthews; F S Hall; L S Wilkinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.